[Progressive vaccinia]. 1977

L Tímár, and J Budai, and G Nyerges, and R Szigeti, and I Hollós, and I Sonkoly

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D005734 Gangrene Death and putrefaction of tissue usually due to a loss of blood supply. Gangrenes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012900 Smallpox Vaccine A VACCINIA VIRUS vaccine used for immunization against SMALLPOX. It is now recommended only for laboratory workers exposed to SMALLPOX VIRUS. Certain countries continue to vaccinate those in the military service. Rare complications most often associated with older generation smallpox vaccines include VACCINIA, secondary bacterial infections, and ENCEPHALOMYELITIS. Because MONKEYPOX VIRUS and SMALLPOX VIRUS are both ORTHOPOXVIRUS and are closely related smallpox vaccines provide effective CROSS-PROTECTION against MPOX (MONKEYPOX) (https://www.cdc.gov/poxvirus/monkeypox/clinicians/smallpox-vaccine.html). Monkey Pox Vaccine,Monkeypox Vaccine,Monkeypox and Smallpox Vaccine,Mpox Vaccine,Mpox and Smallpox Vaccine,Small Pox Vaccine,Smallpox and Monkeypox Vaccine,Smallpox and Mpox Vaccine,Vaccinia Vaccine,Vaccine, Monkey Pox,Vaccine, Monkeypox,Vaccine, Mpox,Vaccine, Small Pox,Vaccine, Smallpox,Vaccine, Vaccinia
D014165 Transfer Factor Factor derived from leukocyte lysates of immune donors which can transfer both local and systemic cellular immunity to nonimmune recipients. Dialyzable Leukocyte Extract,Extract, Dialyzable Leukocyte,Factor, Transfer,Leukocyte Extract, Dialyzable
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D014615 Vaccinia The cutaneous and occasional systemic reactions associated with vaccination using smallpox (variola) vaccine. Vaccinias

Related Publications

L Tímár, and J Budai, and G Nyerges, and R Szigeti, and I Hollós, and I Sonkoly
February 1973, The Journal of the Kentucky Medical Association,
L Tímár, and J Budai, and G Nyerges, and R Szigeti, and I Hollós, and I Sonkoly
March 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
L Tímár, and J Budai, and G Nyerges, and R Szigeti, and I Hollós, and I Sonkoly
January 1970, The Journal of pathology,
L Tímár, and J Budai, and G Nyerges, and R Szigeti, and I Hollós, and I Sonkoly
March 1967, The New England journal of medicine,
L Tímár, and J Budai, and G Nyerges, and R Szigeti, and I Hollós, and I Sonkoly
August 1958, British medical journal,
L Tímár, and J Budai, and G Nyerges, and R Szigeti, and I Hollós, and I Sonkoly
January 1978, Indian pediatrics,
L Tímár, and J Budai, and G Nyerges, and R Szigeti, and I Hollós, and I Sonkoly
October 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
L Tímár, and J Budai, and G Nyerges, and R Szigeti, and I Hollós, and I Sonkoly
May 1981, The Western journal of medicine,
L Tímár, and J Budai, and G Nyerges, and R Szigeti, and I Hollós, and I Sonkoly
May 1962, British medical journal,
L Tímár, and J Budai, and G Nyerges, and R Szigeti, and I Hollós, and I Sonkoly
January 1980, Scandinavian journal of infectious diseases. Supplementum,
Copied contents to your clipboard!